DOI: https://dx.doi.org/10.18203/2320-1770.ijrcog20221944
Published: 2022-07-27

Pregnancy outcome in anti-thyroid peroxidase antibody negative subclinical hypothyroid women with and without treatment

Sagarika Roy, Babita Saha, Sajal Datta

Abstract


Background: There is insufficient evidence in the literature whether pregnancy with anti-thyroid peroxidase antibody negative subclinical hypothyroidism is benefited with treatment.

Methods: The 100 uncomplicated primigravida women before 16 weeks of gestation who were anti thyroid peroxidase antibody negative and diagnosed as subclinical hypothyroid based on serum thyroid stimulating hormone (TSH), Free T4 (FT4) and anti-thyroid peroxidase antibody (anti TPO Ab) were enrolled in this study. They were divided into case and control group having 50 patients in each arm. Case group were treated with levothyroxine therapy as per the recommended dose. Maternal and perinatal outcome were compared between the two groups.

Results: In our study we had found increased percentage of cases of antepartum hemorrhage (APH), pregnancy induced hypertension (PIH), pre-labour rupture of membrane (PROM), preterm delivery, meconium-stained liquor, intrauterine growth restriction (IUGR), low birth weight (LBW), APGAR score at 1 and 5 minutes, neonatal hyperbilirubinemia and NICU admission among women who were not treated but it was not statistically significant when compared with control group.

Conclusions: When compared between the treated and non-treated group in anti TPO Ab negative subclinical hypothyroid patients, we didn’t find any significant difference in parameters studied by us. In view of inadequate literature, controversy exists whether to treat or not anti TPO negative subclinical hypothyroidism in pregnancy with levothyroxine.


Keywords


Subclinical hypothyroid, Anti thyroid peroxidase antibody, Levothyroxine

Full Text:

PDF

References


Mohanty R, Patnaik S, Ramani B. Subclinical hypothyroidis during pregnancy: A clinical review. Ind J Clin Pract. 2014;25(5):449-54.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid. 2011;21(10):1081-25.

Nor Azlin MI, Bakin YD, Mustafa N, Wahab NA, Johari MJ, Kamarudin NA et al. Thyroid autoantibodies and associated complications during pregnancy. J Obstetr Gynaecol. 2010;30(7):675-8.

Erik K Alexander, Elizabeth N Pearce, Gregory A Brent, Rosalind S Brown et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid.2017;27(3):315-89.

Wang S, Teng WP, Li JX, Wang WW, Shan ZY. Effects of maternal subclinical hypothyroidism on obstetrical outcomes during early pregnancy. J Endocrinological Investigation. 2012;35(3):322-5.

Singh G, Kaul I, Singh A, Meinia SK. Maternal and fetal outcome in subclinical hypothyroidism in Jammu region, North India. Int J Reproduct Contracept Obstetr Gynecol. 2016;5(7):2362-6.

Tudela CM, Casey BM, McIntire DD, Cunningham FG. Relationship of subclinical thyroid disease to the incidence of gestational diabetes. Obstetr Gynecol. 2012 ;119(5):983-8.

Maraka S, Singh Ospina NM, O'Keeffe DT, Rodriguez-Gutierrez R, Espinosa De Ycaza AE et al. Coddington III CC, Montori VM, Stan MN. Effects of levothyroxine therapy on pregnancy outcomes in women with subclinical hypothyroidism. Thyroid. 2016;26(7):980-6.

Liu H, Shan Z, Li C, Mao J, Xie X, Wang W et al. Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid. 2014;24(11):1642-9.

Ma L, Qi H, Chai X, Jiang F, Mao S, Liu J et al. The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes: a prospective multicenter single-blind, randomized, controlled study of thyroid function screening test during pregnancy. J Maternal-Fetal Neonatal Med. 2016;29(9):1391-4.

Maraka S, Mwangi R, McCoy RG, Yao X, Sangaralingham LR, Ospina NM et al. Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment. BMJ. 2017;356:i6865.

Nazarpour S, Ramezani Tehrani F, Simbar M, Tohidi M, Minooee S, Rahmati M et al. Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies. J Clin Endocrinol Metabol. 2017;103(3):926-35.

Blumenthal NJ, Eastman CJ. Beneficial effects on pregnancy outcomes of thyroid hormone replacement for subclinical hypothyroidism. J Thyroid Res. 2017;2017.